Pharmacopeia
METOCLOPRAMIDE
Core pharmacology
- Class Group
Anti-emetic
Dopamine Antagonist
- Legacy Cicm Level
Level 3
- Indications Uses
1. Prokinetic
2. Antiemetic
3. Migraine
4. Reflux oesophagitis- Presentation
PO/IV
- Physiological effects
CVS: Hypotension after IV; Dysrhythmias and QTc
GIT
1. Selective stimulation of gastric muscarinic receptors
- Coordinated GIT contraction (accelerates gastric emptying)
- Increased amplitude and frequency of Longitudinal muscle contraction
- Lowers threshold for peristaltic reflex to occur
2. Direct action on smooth muscle to increase tone (including increased LOS)
3. Reduces intestinal muscle fatigueCNS
- Neuroleptic effects
- Extrapyramidal effects
- Increase prolactinGU- Increased uterine peristalsis
- Protein binding
20% PB
Gastrointestinal · Gastrointestinal
- Introduction
Benzamide D2-R antagonist
- Mechanism of action
1. Decreased sensitivity of visceral afferents to vomit center
2. Central D2 blockade increased threshold at CTZ
3. Selective GIT muscarinic effects leading to prokinesis
4. Other effects:
- Inhibition of 5-HT3
- Anti-H1 effects- Adverse Effects Toxicity
1. EPS
2. Dizziness
3. NMS
4. QTc prolongation- Absorption
Rapid oral absorption with variable BA (30-90%) due to first pass conjugation
- Volume of distribution
Vd 2-3L/Kg
- Metabolism
Hepatic metabolism to sulfate conjugate
- Excretion
80% renally excreted (20% of this is unchanged)
- Half-life
T1/2= 2.5-5 hours
- Introduction
Dopamine Antagonist
- Mechanism of action
1. Antagonism of peripheral D2 receptors
2. Selective stimulation of gastric muscarinic receptors
- Coordinated GIT contraction
- Increased amplitude and frequency of Longitudinal muscle contraction
- Lowers threshold for peristaltic reflex to occur
3. Direct action on smooth muscle to increase tone (including increased LOS)
4. Reduces intestinal muscle fatigue
5. Decreased sensitivity of visceral afferents to vomit center
6. Central D2 blockade increased threshold at CTZ- Adverse Effects Toxicity
1. Drowsiness, dizziness and fainting
2. EPS- including oculogyric crises
3. Neuroleptic malignant syndrome
4. QTc prolongation and conduction abnormalities
5. Abdominal cramping
6. Hyperprolactinaemia
7. Hypertension in phaeochromocytoma- Absorption
Rapidly absorbed with variable F (30-100%) due to First pass metabolism
- Volume of distribution
Vd 2-3.5L/kg
- Metabolism
Hepatic sulfate conjugation
Excretion- Excretion
80% renally excreted, 20% of this unchanged
- Half-life
T1/2= 2-5 hours